Aftermath of merger and FDA decision could be huge for Wright Medical
After committing to grow its extremities business through its sale of its OrthoRecon business in 2013, Wright Medical Group's merger with Tornier and the U.S. Food & Drug Administration's approvable letter for its Augment Bone Graft product, the company is moving full speed ahead.
Wright Medical announced the merger and the progress with Augment yesterday, but during a conference call yesterday afternoon, Bob Palmisano, Wright Medical's CEO, tried to temper expectations when it comes to the company's…
Source: bizjournals.com Health Care:Pharmaceuticals headlines - Category: Pharmaceuticals Authors: Michael Sheffield Source Type: news
More News: Bone Graft | Conferences | Health | Health Management | Mergers and Aquisitions | Pharmaceuticals